EcoDrugPlus

Solute Carrier Family 6 Member 2

Ensembl ID : ENSFCAG00000014317
Gene Symbol: SLC6A2
5 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSFCAG00000002581
Gene Symbol: SLC6A3
3 Cross references
167 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSFCAG00000005906
Gene Symbol: SLC6A4
3 Cross references
205 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSFCAG00000006493
Gene Symbol: SLC6A9
5 Cross references
206 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSFCAG00000015433
Gene Symbol: SLC9A3
5 Cross references
238 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSFCAG00000009489
Gene Symbol: SSTR1
3 Cross references
160 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSFCAG00000004735
Gene Symbol: SSTR2
5 Cross references
264 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSFCAG00000022777
Gene Symbol: SSTR4
5 Cross references
102 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSFCAG00000004225
Gene Symbol: SSTR5
5 Cross references
257 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSFCAG00000038645
Gene Symbol: SPHK2
5 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSFCAG00000006919
Gene Symbol: S1PR1
3 Cross references
194 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSFCAG00000014214
Gene Symbol: SYK
5 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).